Preoperative serum tumor marker levels in Gastric Cancer

被引：2
作者：
Polat, Erdal [4 ,5 ]
Duman, Ugur [1 ]
Duman, Mustafa [4 ,5 ]
Peker, Kivanc Derya [4 ,5 ]
Akyuz, Cebrail [4 ,5 ]
Yasar, Necdet Fatih [4 ,5 ]
Uzun, Orhan [4 ,5 ]
Akbulut, Sabiye [2 ,5 ]
Bostanci, Erdal Birol [3 ]
Yol, Sinan [4 ,5 ]
机构：
[1] Bursa Sevket Yilmaz Training & Res Hosp, Dept Gen Surg, Bursa, Turkey
[2] Turkiye High Specialty Training & Res Hosp, Dept Gastroenterol, Ankara, Turkey
[3] Turkiye High Specialty Training & Res Hosp, Dept Gastrointestinal Surg, Ankara, Turkey
[4] Dept Gastrointestinal Surg, Istanbul, Turkey
[5] Kosuyolu High Specialty Training & Res Hosp, Istanbul, Turkey
来源：
PAKISTAN JOURNAL OF MEDICAL SCIENCES | 2014年 / 30卷 / 01期
关键词：
Gastric cancer; Peritoneal carcinomatozis; Serum tumor markers; CARCINOEMBRYONIC ANTIGEN LEVELS; PROGNOSTIC VALUE; INTRAPERITONEAL PACLITAXEL; CEA LEVELS; CA-19-9; CA19-9; CHEMOTHERAPY; STOMACH; CA-72-4; CA125;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: Tumor markers have shown little benefit as a method for screening. However, they can be used clinically for the monitoring of tumor recurrence and used as prognostic factors because higher levels have been observed in advanced disease. This study aimed to investigate the relationship between the preoperative tumor marker levels and different clinical aspects of gastric cancer. Methods: One hundred and six consecutive patients with confirmed diagnosis of gastric cancer and 106 subjects (age and sex matched) with no malignancy as control group were included prospectively in this study in 3 years. The relationships between tumor markers CEA, CA 19-9 and stage of disease, tumor differentiation, presence of ringlet cell type, presence of peritoneal carcinomatozis were investigated. Results: The serum CEA and CA 125 levels were found to be significantly elevated in gastric cancer patients than in controls. The serum level of CEA had showed a significant elevation with the presence of distant metastasis. The CA 19-9 and CA 125 levels had showed significant elevations with the presence of peritoneal carcinomatozis. Conclusions: This study showed that there is a limited clinical benefit of preoperative tumor marker measurements in gastric cancer such as estimation of peritoneal dissemination.
引用
收藏
页码：145 / 149
页数：5
相关论文
共 55 条
[1]  
[Anonymous], COCHRANE DATABASE SY
[2]   CARCINOEMBRYONIC ANTIGEN, A HUMAN-TUMOR MARKER, FUNCTIONS AS AN INTERCELLULAR-ADHESION MOLECULE [J].
BENCHIMOL, S ;
FUKS, A ;
JOTHY, S ;
BEAUCHEMIN, N ;
SHIROTA, K ;
STANNERS, CP .
CELL, 1989, 57 (02) :327-334
[3]  
Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23
[4]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[5]  
DITTRICH C, 1985, CANCER DETECT PREV, V8, P181
[6]   The prognostic significance of preoperative sevum CA 19-9 in patients with resectable gastric carcinoma:: Comparison with CEA [J].
Duraker, N ;
Çelik, AN .
JOURNAL OF SURGICAL ONCOLOGY, 2001, 76 (04) :266-271
[7]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[8]   Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination [J].
Emoto, Shigenobu ;
Ishigami, Hironori ;
Yamashita, Hiroharu ;
Yamaguchi, Hironori ;
Kaisaki, Shoichi ;
Kitayama, Joji .
GASTRIC CANCER, 2012, 15 (02) :154-161
[9]   Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer [J].
Fujimura, T ;
Kinami, S ;
Ninomiya, I ;
Kitagawa, H ;
Fushida, S ;
Nishimura, G ;
Kayahara, M ;
Shimizu, K ;
Ohta, T ;
Miwa, K .
ENDOSCOPY, 2002, 34 (07) :569-574
[10]  
GRIMM T, 1995, CANCER RES, V55, P3254
123456